1.Gut dysbiosis impairs intestinal renewal and lipid absorption in Scarb2 deficiency-associated neurodegeneration.
Yinghui LI ; Xingchen LIU ; Xue SUN ; Hui LI ; Shige WANG ; Wotu TIAN ; Chen XIANG ; Xuyuan ZHANG ; Jiajia ZHENG ; Haifang WANG ; Liguo ZHANG ; Li CAO ; Catherine C L WONG ; Zhihua LIU
Protein & Cell 2024;15(11):818-839
Scavenger receptor class B, member 2 (SCARB2) is linked to Gaucher disease and Parkinson's disease. Deficiency in the SCARB2 gene causes progressive myoclonus epilepsy (PME), a rare group of inherited neurodegenerative diseases characterized by myoclonus. We found that Scarb2 deficiency in mice leads to age-dependent dietary lipid malabsorption, accompanied with vitamin E deficiency. Our investigation revealed that Scarb2 deficiency is associated with gut dysbiosis and an altered bile acid pool, leading to hyperactivation of FXR in intestine. Hyperactivation of FXR impairs epithelium renewal and lipid absorption. Patients with SCARB2 mutations have a severe reduction in their vitamin E levels and cannot absorb dietary vitamin E. Finally, inhibiting FXR or supplementing vitamin E ameliorates the neuromotor impairment and neuropathy in Scarb2 knockout mice. These data indicate that gastrointestinal dysfunction is associated with SCARB2 deficiency-related neurodegeneration, and SCARB2-associated neurodegeneration can be improved by addressing the nutrition deficits and gastrointestinal issues.
Animals
;
Mice
;
Dysbiosis/metabolism*
;
Mice, Knockout
;
Humans
;
Lysosomal Membrane Proteins/genetics*
;
Receptors, Scavenger/genetics*
;
Gastrointestinal Microbiome
;
Myoclonic Epilepsies, Progressive/genetics*
;
Vitamin E Deficiency/complications*
;
Neurodegenerative Diseases/genetics*
;
Bile Acids and Salts/metabolism*
;
Male
;
Lipid Metabolism
;
Intestinal Mucosa/pathology*
2.Association Analysis Between Methylation of SCARB1 Gene Promoter and Coronary Heart Disease.
Wei LI ; Zhen-Hua WANG ; Peng SHI ; Song XUE
Acta Academiae Medicinae Sinicae 2023;45(3):405-409
Objective To explore the relationship between scavenger receptor class B member 1 (SCARB1) gene promoter methylation and the pathogenesis of coronary artery disease. Methods A total of 120 patients with coronary heart disease treated in Renji Hospital affiliated to Shanghai Jiao Tong University School of Medicine from December 2018 to May 2020 were selected as the case group,while 140 gender and age matched healthy participants were randomly selected as the control group for a case-control study.The methylation status was detected by high-throughput target sequencing after bisulfite converting,and the methylation of CpG sites in the promoter region of SCARB1 gene was compared between the two groups. Results The case group showed higher methylation level of SCARB1+67 and lower methylation level of SCARB1+134 than the control group (both P<0.001),and the differences remained statistically significant in men (both P<0.001) and women (both P<0.001).The overall methylation level in the case group was lower than that in the control group [(80.27±2.14)% vs.(81.11±1.27)%;P=0.006],while this trend was statistically significant only in men (P=0.002). Conclusion The methylation of SCARB1 gene promotor is associated with the pathogenesis and may participate in the occurrence and development of coronary heart disease.
Male
;
Humans
;
Female
;
Methylation
;
Case-Control Studies
;
China
;
Coronary Artery Disease/genetics*
;
Promoter Regions, Genetic
;
DNA Methylation
;
Scavenger Receptors, Class B/genetics*
3.H19 recruited N 6 -methyladenosine (m 6 A) reader YTHDF1 to promote SCARB1 translation and facilitate angiogenesis in gastric cancer.
Rumeng BAI ; Miaomiao SUN ; Yuanyuan CHEN ; Shuaishuai ZHUO ; Guoxin SONG ; Tianjun WANG ; Zhihong ZHANG
Chinese Medical Journal 2023;136(14):1719-1731
BACKGROUND:
Angiogenesis is described as a complex process in which new microvessels sprout from endothelial cells of existing vasculature. This study aimed to determine whether long non-coding RNA (lncRNA) H19 induced the angiogenesis of gastric cancer (GC) and its possible mechanism.
METHODS:
Gene expression level was determined by quantitative real-time polymerase chain reaction and western blotting. Cell counting kit-8, transwell, 5-Ethynyl-2'-deoxyuridine (EdU), colony formation assay, and human umbilical vein endothelial cells (HUVECs) angiogenesis assay as well as Matrigel plug assay were conducted to study the proliferation, migration, and angiogenesis of GC in vitro and in vivo . The binding protein of H19 was found by RNA pull-down and RNA Immunoprecipitation (RIP). High-throughput sequencing was performed and next Gene Ontology (GO) as well as Kyoto Encyclopedia of Genes and Genomes (KEGG) analysis was conducted to analyze the genes that are under H19 regulation. Methylated RIP (me-RIP) assay was used to investigate the sites and abundance among target mRNA. The transcription factor acted as upstream of H19 was determined through chromatin immunoprecipitation (ChIP) and luciferase assay.
RESULTS:
In this study, we found that hypoxia-induced factor (HIF)-1α could bind to the promoter region of H19, leading to H19 overexpression. High expression of H19 was correlated with angiogenesis in GC, and H19 knocking down could inhibit cell proliferation, migration and angiogenesis. Mechanistically, the oncogenic role of H19 was achieved by binding with the N 6 -methyladenosine (m 6 A) reader YTH domain-containing family protein 1 (YTHDF1), which could recognize the m 6 A site on the 3'-untransated regions (3'-UTR) of scavenger receptor class B member 1 (SCARB1) mRNA, resulting in over-translation of SCARB1 and thus promoting the proliferation, migration, and angiogenesis of GC cells.
CONCLUSION
HIF-1α induced overexpression of H19 via binding with the promoter of H19, and H19 promoted GC cells proliferation, migration and angiogenesis through YTHDF1/SCARB1, which might be a beneficial target for antiangiogenic therapy for GC.
Humans
;
Cell Line, Tumor
;
Cell Proliferation/genetics*
;
Endothelial Cells/metabolism*
;
Gene Expression Regulation
;
Gene Expression Regulation, Neoplastic/genetics*
;
Hypoxia
;
MicroRNAs/genetics*
;
RNA
;
RNA, Long Noncoding/metabolism*
;
RNA-Binding Proteins/metabolism*
;
Scavenger Receptors, Class B/metabolism*
;
Stomach Neoplasms/genetics*
4.Sirt1 regulates testosterone biosynthesis in Leydig cells via modulating autophagy.
Muhammad Babar KHAWAR ; Chao LIU ; Fengyi GAO ; Hui GAO ; Wenwen LIU ; Tingting HAN ; Lina WANG ; Guoping LI ; Hui JIANG ; Wei LI
Protein & Cell 2021;12(1):67-75
Animals
;
Autophagy/genetics*
;
Cholesterol/metabolism*
;
Gene Expression Regulation
;
Integrases/metabolism*
;
Leydig Cells/metabolism*
;
Male
;
Mice, Knockout
;
Multienzyme Complexes/metabolism*
;
Phosphoproteins/metabolism*
;
Primary Cell Culture
;
Progesterone Reductase/metabolism*
;
RNA Splicing Factors/metabolism*
;
Scavenger Receptors, Class B/metabolism*
;
Sequestosome-1 Protein/metabolism*
;
Signal Transduction
;
Sirtuin 1/genetics*
;
Sodium-Hydrogen Exchangers/metabolism*
;
Steroid 17-alpha-Hydroxylase/metabolism*
;
Steroid Isomerases/metabolism*
;
Testosterone/genetics*
5.Study on visfatin-induced inflammation and necroptosis via LOX-1 in human umbilical vein endothelial cells.
Xiaoyu HAN ; Wenchao WU ; Xiaojing LIU ; Ye ZHU
Journal of Biomedical Engineering 2020;37(5):834-841
The aim of the study is to identify the effects and underlying mechanisms of visfatin on inflammation and necroptosis in vascular endothelial cells. Human umbilical vein endothelial cells (HUVECs) were stimulated with visfatin or pretreated with Polyinosinic acid (LOX-1 inhibitor). By using the Western blot, RT-PCR, immunocytochemistry, enzyme-linked immunosorbent assay (ELISA), MTT and flow cytometry technique, the occurrence of inflammation and necroptosis in HUVECs were evaluated. Our results showed that 100 ng/mL visfatin significantly increased the mRNA and protein expression of monocyte chemotactic protein 1 (MCP-1) and LOX-1 after 24 hours' treatment in HUVECs. However, pretreatment with Polyinosinic acid could significantly reduce the expression of MCP-1 compared with visfatin group. Additionally, 100 ng/mL visfatin could induce the production of necrotic features and increase the mRNA expression of BMF (one of the markers of necroptosis), while pretreating with Polyinosinic acid markedly downregulated the mRNA expression of BMF gene and promoted the cell proliferation. These results indicate that visfatin might induce inflammation and necroptosis via LOX-1 in HUVECs, suggesting that visfatin plays a central role in the development of atherosclerosis.
Cells, Cultured
;
Human Umbilical Vein Endothelial Cells
;
Humans
;
Inflammation/chemically induced*
;
Necroptosis
;
Nicotinamide Phosphoribosyltransferase
;
Scavenger Receptors, Class E/genetics*
6.Relationships between Rapid Eye Movement Sleep Behavior Disorder and Neurodegenerative Diseases: Clinical Assessments, Biomarkers, and Treatment.
Min LI ; Li WANG ; Jiang-Hong LIU ; Shu-Qin ZHAN
Chinese Medical Journal 2018;131(8):966-973
ObjectiveRapid eye movement sleep behavior disorder (RBD) is characterized by dream enactment and loss of muscle atonia during rapid eye movement sleep. RBD is closely related to α-synucleinopathies including Parkinson's disease, dementia with Lewy bodies, and multiple system atrophy. Many studies have investigated the markers of imaging and neurophysiological, genetic, cognitive, autonomic function of RBD and their predictive value for neurodegenerative diseases. This report reviewed the progress of these studies and discussed their limitations and future research directions.
Data SourcesUsing the combined keywords: "RBD", "neurodegenerative disease", "Parkinson disease", and "magnetic resonance imaging", the PubMed/MEDLINE literature search was conducted up to January 1, 2018.
Study SelectionA total of 150 published articles were initially identified citations. Of the 150 articles, 92 articles were selected after further detailed review. This study referred to all the important English literature in full.
ResultsSingle-nucleotide polymorphisms in SCARB2 (rs6812193) and MAPT (rs12185268) were significantly associated with RBD. The olfactory loss, autonomic dysfunction, marked electroencephalogram slowing during both wakefulness and rapid eye movement sleep, and cognitive impairments were potential predictive markers for RBD conversion to neurodegenerative diseases. Traditional structural imaging studies reported relatively inconsistent results, whereas reduced functional connectivity between the left putamen and substantia nigra and dopamine transporter uptake demonstrated by functional imaging techniques were relatively consistent findings.
ConclusionsMore longitudinal studies should be conducted to evaluate the predictive value of biomarkers of RBD. Moreover, because the glucose and dopamine metabolisms are not specific for assessing cognitive cognition, the molecular metabolism directly related to cognition should be investigated. There is a need for more treatment trials to determine the effectiveness of interventions of RBD on preventing the conversion to neurodegenerative diseases.
Biomarkers ; blood ; Humans ; Lysosome-Associated Membrane Glycoproteins ; genetics ; Neurodegenerative Diseases ; blood ; genetics ; physiopathology ; Parkinson Disease ; blood ; genetics ; physiopathology ; Polymorphism, Single Nucleotide ; genetics ; REM Sleep Behavior Disorder ; blood ; genetics ; physiopathology ; Receptors, Scavenger ; genetics ; tau Proteins ; genetics
7.The binding of a monoclonal antibody to the apical region of SCARB2 blocks EV71 infection.
Xuyuan ZHANG ; Pan YANG ; Nan WANG ; Jialong ZHANG ; Jingyun LI ; Hao GUO ; Xiangyun YIN ; Zihe RAO ; Xiangxi WANG ; Liguo ZHANG
Protein & Cell 2017;8(8):590-600
Entero virus 71 (EV71) causes hand, foot, and mouth disease (HFMD) and occasionally leads to severe neurological complications and even death. Scavenger receptor class B member 2 (SCARB2) is a functional receptor for EV71, that mediates viral attachment, internalization, and uncoating. However, the exact binding site of EV71 on SCARB2 is unknown. In this study, we generated a monoclonal antibody (mAb) that binds to human but not mouse SCARB2. It is named JL2, and it can effectively inhibit EV71 infection of target cells. Using a set of chimeras of human and mouse SCARB2, we identified that the region containing residues 77-113 of human SCARB2 contributes significantly to JL2 binding. The structure of the SCARB2-JL2 complex revealed that JL2 binds to the apical region of SCARB2 involving α-helices 2, 5, and 14. Our results provide new insights into the potential binding sites for EV71 on SCARB2 and the molecular mechanism of EV71 entry.
Amino Acid Sequence
;
Animals
;
Antibodies, Monoclonal
;
chemistry
;
genetics
;
metabolism
;
Binding Sites
;
Cell Line
;
Crystallography, X-Ray
;
Enterovirus A, Human
;
drug effects
;
genetics
;
growth & development
;
immunology
;
Fibroblasts
;
drug effects
;
virology
;
Gene Expression
;
HEK293 Cells
;
Humans
;
Immunoglobulin Fab Fragments
;
chemistry
;
genetics
;
metabolism
;
Lysosome-Associated Membrane Glycoproteins
;
chemistry
;
genetics
;
immunology
;
Mice
;
Models, Molecular
;
Protein Binding
;
Protein Conformation, alpha-Helical
;
Protein Conformation, beta-Strand
;
Protein Interaction Domains and Motifs
;
Receptors, Scavenger
;
chemistry
;
genetics
;
immunology
;
Receptors, Virus
;
chemistry
;
genetics
;
immunology
;
Recombinant Fusion Proteins
;
chemistry
;
genetics
;
immunology
;
Sequence Alignment
;
Sequence Homology, Amino Acid
;
Sf9 Cells
;
Spodoptera
;
Thermodynamics
8.Advances in research of SCARB2 functions and related disorders.
Miao HE ; Zhen LIU ; Beisha TANG ; Junling WANG
Chinese Journal of Medical Genetics 2015;32(5):723-727
SCARB2 (scavenger receptor class B, member 2) is a lysosomal membrane glucoprotein, which is encoded by SCARB2 gene. It takes vital parts in the physiological and pathological processes including the transportation of beta-glucocerebrosidase to the lysosome, infection of EV71 and load-induced cardiac myocyte hypertrophy. This article has reviewed the molecular structure and functions of SCARB2 gene and its protein, as well as their relationship with diseases.
Hand, Foot and Mouth Disease
;
genetics
;
Humans
;
Lysosome-Associated Membrane Glycoproteins
;
chemistry
;
genetics
;
physiology
;
Myoclonic Epilepsies, Progressive
;
genetics
;
Parkinson Disease
;
genetics
;
Receptors, Scavenger
;
chemistry
;
genetics
;
physiology
9.Prognostic role of genetic biomarkers in clinical progression of prostate cancer.
Maria Jesus ALVAREZ-CUBERO ; Luis Javier MARTINEZ-GONZALEZ ; Maria SAIZ ; Pedro CARMONA-SAEZ ; Juan Carlos ALVAREZ ; Manrique PASCUAL-GELER ; Jose Antonio LORENTE ; Jose Manuel COZAR
Experimental & Molecular Medicine 2015;47(8):e176-
The aim of this study was to analyze the use of 12 single-nucleotide polymorphisms in genes ELAC2, RNASEL and MSR1 as biomarkers for prostate cancer (PCa) detection and progression, as well as perform a genetic classification of high-risk patients. A cohort of 451 men (235 patients and 216 controls) was studied. We calculated means of regression analysis using clinical values (stage, prostate-specific antigen, Gleason score and progression) in patients and controls at the basal stage and after a follow-up of 72 months. Significantly different allele frequencies between patients and controls were observed for rs1904577 and rs918 (MSR1 gene) and for rs17552022 and rs5030739 (ELAC2). We found evidence of increased risk for PCa in rs486907 and rs2127565 in variants AA and CC, respectively. In addition, rs627928 (TT-GT), rs486907 (AG) and rs3747531 (CG-CC) were associated with low tumor aggressiveness. Some had a weak linkage, such as rs1904577 and rs2127565, rs4792311 and rs17552022, and rs1904577 and rs918. Our study provides the proof-of-principle that some of the genetic variants (such as rs486907, rs627928 and rs2127565) in genes RNASEL, MSR1 and ELAC2 can be used as predictors of aggressiveness and progression of PCa. In the future, clinical use of these biomarkers, in combination with current ones, could potentially reduce the rate of unnecessary biopsies and specific treatments.
Aged
;
Aged, 80 and over
;
Cohort Studies
;
Disease Progression
;
Endoribonucleases/*genetics
;
Gene Frequency
;
Genetic Markers/genetics
;
Genetic Predisposition to Disease
;
Humans
;
Male
;
Middle Aged
;
Neoplasm Proteins/*genetics
;
*Polymorphism, Single Nucleotide
;
Prognosis
;
Prostate/metabolism/*pathology
;
Prostatic Neoplasms/*diagnosis/*genetics
;
Scavenger Receptors, Class A/*genetics
10.Effect of Antrodia cinnamomea on gene expression related to aortal endothelial injury in rats with hyperlipidemia.
Jie QI ; Yun TAO ; Jun ZHANG ; Jian FU
China Journal of Chinese Materia Medica 2014;39(9):1670-1674
OBJECTIVETo investigate the effect of Antrodia cinnamomea on gene expression related to aortal endothelial injury of rats with hyperlipidemia.
METHODFifty SD rats were randomly divided into five groups: the normal control group (NG), the model group (MG), the antrodia cinnamomea groups of low, middle and high doses (AC-LG, AC-MG, AC-HG, 250, 500, 1 000 mg x kg(-1)). The rats were fed with high-fat diets to establish the hyperlipidemia model. After the drug administration for 10 weeks, their serum lipid, SOD, MDA and ox-LDL, LOX-1, P38 MAPK and NF-kappaB mRNA and protein expression were respectively determined, and the aortal endothelial injury was observed under electron microscope.
RESULTIn the model group, the contents of TC, TG and LDL-C significant increased (P < 0.01), whereas the content of HDL-C significant decreased (P < 0.01). Compared with the model group, both the AC-M group and the AC-H group showed reduction in endothelial injury and significant decrease in the content of TC, TG and LDL-C (P < 0.05 or P < 0.01). The content of HDL-C increased, but with no significant difference. SOD activity in serum remarkably increased (P < 0.05 or P < 0.01), MDA and ox-LDL levels dramatically decreased (P < 0.05 or P < 0.01).
CONCLUSIONA. cinnamomea can alleviate endothelial lipid injury by inhibiting the expressions of LOX-1, P38MAPK and NF-kappaB in aorta and better protect aortal endothelial cells from oxidative lipid injury.
Animals ; Antrodia ; chemistry ; Aorta ; drug effects ; metabolism ; ultrastructure ; Atherosclerosis ; blood ; genetics ; prevention & control ; Biological Products ; pharmacology ; Cholesterol ; blood ; Cholesterol, HDL ; blood ; Cholesterol, LDL ; blood ; Endothelium, Vascular ; drug effects ; metabolism ; pathology ; Enzyme-Linked Immunosorbent Assay ; Gene Expression ; drug effects ; Hyperlipidemias ; blood ; genetics ; prevention & control ; Lipoproteins, LDL ; blood ; Male ; Malondialdehyde ; blood ; Microscopy, Electron ; NF-kappa B ; blood ; genetics ; metabolism ; Random Allocation ; Rats ; Rats, Sprague-Dawley ; Reverse Transcriptase Polymerase Chain Reaction ; Scavenger Receptors, Class E ; blood ; genetics ; metabolism ; Superoxide Dismutase ; blood ; Triglycerides ; blood ; p38 Mitogen-Activated Protein Kinases ; blood ; genetics ; metabolism

Result Analysis
Print
Save
E-mail